IMPACT REPORT
As the country fights its way through the COVID-19 pandemic, the Mexican health sector strives to consolidate a fragmented service network while overcoming the challenges of both medicine and care shortages. At the same time, Mexico keeps growing its manufacturing muscle in both pharmaceutical and medical devices segments, creating new investment opportunities.
The success of the Mexican health industry will be defined by the business and political leaders shaping its future today. We bring these leaders together at Mexico Health Summit to exchange essential industry information, expertise and opportunities, to find solutions to overcome industry challenges, to connect financing and opportunities, to match supply and demand and to accelerate innovation. In 2021, the two editions of Mexico Health Summit brought together 630 industry leaders representing 295 companies, welcomed 124 speakers, generated 2,586 matchmaking interactions that resulted in 306 high-level 1:1 meetings, and generated 975 pre-qualified leads for 20 sponsors.
In 2022, we will continue maximizing the impact of our conferences for participants, speakers and sponsors. Our conference programs will offer inside perspectives on the topics that matter most, and are designed to help industry leaders make better decisions and drive results. By leveraging leading-edge technology and artificial intelligence, we will deliver unprecedented matchmaking and lead-generation results at a time when connecting supply and demand remains challenging. We look forward to helping you achieve your marketing, commercial and strategic objectives!
J A nu AR y 27-29 , 2021
Gold Sponsors
Registration Sponsor
Se PT e MB e R 08-10 , 2021
Platinum Sponsor n etworking Sponsor
Gold Sponsors
295 companies
630 conference participants
124 speakers
20 sponsors
4,003 visitors to the conference website
How would you rate the quality of the conference program and speakers?
Breakdown by job title
Mexico’s leading B2B conference organizer introduces the world’s leading event networking platform.
Delivering intent-based matchmaking powered by Artificial Intelligence that connects the right people. n etwork, no matter where you are.
477 participants
How would you rate the quality of the matchmaking on Brella?
Matchmaking intentions
2,586 matchmaking communications
306 1:1 meetings conducted
4,597
• Abbott Laboratories, Inc.
• AbbVie
• Accord farma
• Aes
• Aesculapius Baer
• AIDICAR e
• Akza
• Alivia Clinica de Alta e specialidad
• Allen Laboratorios
• Allergan
• Alvarez & Marsal
• Amazon
• Ambar Capital
• AM eLAf
• AMID Asociacion Mexicana de Industrias Innovadoras de Dispositivos Médicos AC
• AMII f
• Anadim
• Analitek- Bio satefy
• An ICAnn
• Apolo Health
• Apotex
• ARROBA I n G en I eRIA, SA D e CV
• Ascendis Capital
• Asociación mexicana de diabetes en la Ciudad de México AC
• Asociación Mexicana de Laboratorios farmacéuticos, A.C.
• Asociación Mexicana de Laboratorios farmacéuticos
• ASPen LABS
• Astellas
• Atramat
• AVA Salud
• Avalon Pharmaceutical
• AXA Seguros México
• Axios International
• Baker Mackenzie
• Becerril, Coca & Becerril
• Beckman Coulter
• Biocodex de Mexico
• BioMérieux
• BIOSKI n CO
• Boehringer Ingelheim
• Boston Scientific
• BPf part of WbD Group
• Brella Ltd
• Brightsea
• Bristol Myers Squibb
• British embassy in Mexico
• Bupa
• Cal y Mayor
• Canifarma
• Cardinal Health
• Carestream
• Central Media
• Centro de Investigación Sophia
• Centro Médico ABC
• CHG Meridian Mexico
• Chiesi Mexico
• CHRISTuS Center of e xcellence and Innovation
• Christus Muguerza
• Circutor
• CIS ne México (Centro de Investigación en Sistema n ervioso)
• Citieffe
• City Cancer Challenge
• City Council
• Cluster Medico Jalisco
• Cold Chain Technologies
• COLORCO n
• Consejo Coordinador empresarial
• Consejo de Salubridad General
• Consejo Mexicano de n uerología
• Consejo Mexicano de Ortopedia y Traumatología
• Consorcio Mexicano de Hospitales
• ConvaTec Mexico
• Croda
• D eG
• D eLL Technologies
• DocPlanner
• Dräger
• ecaresoft Inc.
• edwards Lifesciences Mexico SA de CV
• ekomite
• eli Lilly & Company
• embassy of Canada in Mexico
• embassy of the n etherlands in Mexico
• energy to Market
• eolis
• ergotron
• everis
• fAnASA
• farmacéuticos Maypo, S.A. de C.V.
• farmacia Guadalajara, SA de CV
• farmacias ISS eG
• farmacos Continentales S. A de C.V
• farmalisto
• fARMAPI eL
• farmcias yza
• ferring
• fronier View
• frontierView
• fundación Mexicana para la Salud.A.C.
• Generac México
• General Consulate of Canada
• Genetics and Health SA de CV
• Gilead
• Gobierno de Ontario en Mexico
• Google Cloud
• GR e Relaciones e stratégicas
• Grupo Angeles Serivicios de Salud
• Grupo Bruluart
• GR u PO DALI n D e SAn An G eL I nn
• Grupo GS México
• Grupo Médico Rossano
• Grupo Promotor de la Industria de Cannabis
• Grupo Sanfer
• Grupo Torre Médica
• Grupo Viso
• GSK
• HL7 México
• Hospital Ginequito
• Hospital Moscati
• Hospital San Angel Inn Chapultepec
• Hospitales San Angel Inn
• Hospitales Star Medica
• Hospitaria
• ICAn
• Icon Group
• IMSS
• IMSS ABC
• Indra
• Inosan Biopharma
• Instituto de Salud Pública de Chile
• Instituto Mexicano del Seguro Social
• Insumos para la Salud
• I nTeRACIO nAL fARMAC euTICA
• Internacional farmaceutica
• Investigacion farmaceutica
• IQVIA
• Janssen
• Johnson & Johnson
• Jones Day
• Kaspersky
• Kimberley Clark
• Klockner Pentaplast
• Kuehne n agel
• Laboratorio Médico Polanco
• Laboratorios Alfasigma
• Laboratorios de e specialidades Inmnuológicas
• Laboratorios Liomont
• Laboratorios Sanfer
• Laboratorios Sophia
• LAVARTe X
• Life Sciences Consultants
• LMP
• MAG Medical Group
• Mayo Clinic
• Medartis
• Medica Sur
• MediHC
• Medisi America
• Medistik
• Medix
• Medtronic
• Merck
• Mexico Salud
• MexicoView
• Microport
• Minsait Indra
• Moksha8
• MSD
• Multiplica
• Multivac
• Mural Med
• n adro
• n ewlink
• n ovartis
• Olivares
• Olympus
• Omron
• Pantaleon
• Pascual Asesoria
• perrigo mexico
• Pharma Advice
• Pierre fabr
• PLM
• Prevem Seguros
• QbD México
• Reinsurance Company
• RGA
• RM Pharma Specialist
• Roche
• San Luis Potosi City Council
• Sanchez Devanny
• Sandoz Mexico
• Sanofi
• SARSTeDT M e XICO
• Sartorius
• SBL Pharmaceutical
• Seca
• Sericio de Logística empresarial y Comercial
• Siemens Healthineers
• Silanes
• Social Diabetes
• Sociedad Mexicana de Oncología
• SOHI n
• Somar
• Stripe
• Synthon Mexco
• T5DC
• Takeda
• Tec Salud
• Teconológico de Monterrey
• Teva Pharmaceuticals
• TIS
• Tokio Marine Mexico
• Total Integridad & Certeza
• Trifermed
• Trilations
• Trout & Partners
• uAn L
• u CI n M eDICA
• u DIM eB
• u LTRA LABORATORIOS
• u ltragenyx Pharmaceuticals
• un IVeRSIDAD D e G uADALAJARA
• u niversidad de Monterrey
• u niversidad Iberoamericana
• Veeam
• Vitamedica
• Viveo Health
• Von Wobeser y Sierra
• Willscot
• Within3
• Wood
• Zacsoft
• Zydus Pharmaceuticals Mexico
09:00 STATE OF THE SECTOR: FROM STRUCTURAL REFORMS TO COVID-19
Speaker: Patrick Devlyn, President of the Health Commission at CC e
09:45 THE HEALTHCARE SECTOR IN THE NATIONAL ECONOMY
Moderator: Juan de Villafranca, e xecutive Director of the Mexican Association of Pharmaceutical Laboratories (AM eLAf )
Panelists: Arturo Morales, Corporate Affairs Director at Landsteiner Scientific and President of AM eLAf
Deyanira Chiñas, Commercial Director of T5DC and President of the n ational College of Pharmaceutical Biologists of Mexico
Carlos López Patán, Director General of Medix
Luis Verduzco, Director General of Gelpharma
Fernando Riedel, C eO of SBL Pharmaceuticals
10:30 PHARMACEUTICAL INDUSTRY GOING THROUGH INTENSE THERAPY
Moderator: Rafael Gual, Director General of the n ational Chamber of the Pharmaceutical Industry (CAn I fARMA)
Panelists: Arturo de la Rosa, General Manager of AbbVie Mexico
Karel Fucikovsky, Pharma Director at Pierre fabre Mexico
Juan Luis Serrano, Life Sciences and Intellectual Property Partner at Sánchez Devanny
11:15 HOW TO THRIVE IN THE NEW CENTRALIZED PURCHASING SCHEMESSY
Moderator: Benjamin Vega, Commercial DIrector of Allen Laboratories
Panelists: Marco Ruggiero, General Manager of Chiesi Mexico
José Luis Ortiz, Director General of Medistik
Carlos Gutierrez Muñoz, Account and Sourcing Implementation Director of Christus CeI
12:00 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
12:45 IMPORTANCE OF PREVENTION AND COST OF CHRONIC DISEASES
Speaker: David Kershenobich, Director General of I n CM n SZ
13:30 VALUE-BASED HEALTHCARE: A NOVEL APPROACH TO CARE
Moderator: Rosa María Galindo Suárez, Corporate Affairs and Access Director of GSK
Panelists: Diego Guarin, Regional Market Access Lead for Latin America of Merck MSD
Augusto Muench, C eO of Boehringer Ingelheim Mexico, Central America and Caribbean
Javier Pico, Partner of LifeSciences Consultants
Sandra Sánchez-Oldenhage, President of PharmAdvice Consulting
14:15
NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
15:00 DIAGNOSING HEALTHIER SCENARIOS, STRENGTHENING HEALTHCARE PROVISION
Moderator: Montserrat Galindo, Market Access Manager of 3M Healthcare Division
Panelists: Alejandro Paolini, Vice President of AMID
Cesar Marron, General Manager of Cardinal Health Mexico
Adriana De Villa, Commercial Director of Atramat
15:45 CANNABIS: WINDOW OF OPPORTUNITIES
Moderator: Erick Ponce, Cannabis Industry Promoting Group (GPIC)
Panelists: Cristina Viruega, Director General of TIC I nTL
Fernando Becerril, Senior Partner of Becerril, Coca & Becerril (BC&B)
Guillermo Nieto, President of The Mexican Association of the Cannabis Industry (An ICAnn)
17:00 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
19:00 END OF DAY 1
J A nu AR y 28 TH , 2021
09:00 RUNNING AGAINST THE CLOCK: DEVELOPING A COVID-19 VACCINE
Speaker: Cecilia Padierna, Business Development Manager of LeI
Panelists: Yolanda Cervantes, Vaccine Medical Director at GSK Mexico
Mario Sturion, Managing Director of Janssen Mexico
Juan Silanes, C eO of Inosan Biopharma
10:00 OUT-OF-POCKET EXPENDITURE VS COVID-19
Moderator: Eduardo Lara, Vice President, Head of Health Latin America of Reinsurance Group of America (RGA)
Panelists: Héctor Martínez-Said, President of the Mexican Society of Oncology (SM eO)
Javier Potes, Director General of Consorcio Mexicano de Hospitales (CMH)
Eduardo Garcia Luna, Vice Chancellor Of Health Sciences of u D eM
10:45 DEVELOPING A COVID-19 DIAGNOSIS TEST – BIOMÉRIEUX
Speaker: Héctor Barillas, Director General of bioMérieux
12:00 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
12:45 PHARMACY-ADJACENT MEDICAL OFFICES: SOLUTION TO INCREASE ACCESS
Moderator: Lourdes López, e xecutive Director of the n ational Association of Medicine Distributors (AnADIM)
Panelists: Santiago Gonzalez Reyes, Operations Director of farmacias y ZA
Gabriel Zavala, e xecutive Commercial Director of farmacias del Ahorro
Juan José Aguirre, Commercial Director of Grupo Bruluart
13:30 TELEMEDICINE TO INCREASE HEALTHCARE ACCESS: THE IMPACT OF COVID-19
Moderator: José Antonio Crespo, C eO of farmalisto
Panelists: Juan Manuel Cáceres, C eO of Aidicare
Christian López-Silva, Partner and Head of Healthcare & Life Sciences at Baker McKenzie
Ricardo Moguel, Country Manager for Mexico, Colombia and Argentina at Doctoralia
Alessio Hagen, Director of Smart Cities Latin America of Dell Technologies
14:15 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
15:00 TECHNOLOGY ENHANCING PATIENT CARE
Moderator: Mario Sicilia, Member of the Board of Laboratorio Medico Polanco and Managing Partner of ProActive Capital
Panelists: Jesus Diaz Garaygordobil, CIO of Christus Muguerza
Ricardo Renteria, Sales Management enterprise Lead Latam of Amazon Web Services (AWS)
Mario Muniz, General Manager n orth LATAM of IQVIA
Enrique Mendez, Territory Account Manager of ergotron
15:45 INTERNATIONAL PERSPECTIVES OF COVID-19
Speaker: Corin Robertson, Her Majesty’s Ambassador to the British embassy in Mexico
17:00 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
19:00 END OF MEXICO HEALTH SUMMIT 2021
09:00 DIPLOMACY, SOLIDARITY STAND AGAINST WORST GLOBAL PANDEMIC
Speaker: Martha Delgado Peralta, u ndersecretary for Multilateral Affairs and Human Rights at Mexican Ministry of foreign Affairs
09:30 MEXICO OUTLOOK IN 2022: PREPARE TO CAPTURE BUSINESS OPPORTUNITIES AMID A CHALLENGING OPERATING ENVIRONMENT
Speaker: Alejandro Valerio, Associate Practice Leader Mexico and Central America of frontierView
10:00 PUBLIC-PRIVATE COLLABORATIONS TO CREATE HIGH-QUALITY SERVICES
Moderator: Hector Valle, e xecutive President of funsalud
Panelists: Javier Potes, Director General of CMH
Raul Anaya Nuñez, Director General of Certificación at Consejo de Salubridad General
Patrick Devlyn, President of the Health Commission at CC e
10:45 BOOSTING HEALTHCARE UTILIZATION BY ADDRESSING FINANCIAL HARDSHIP
Moderator: Javier Potes, Director General of CMH
Panelists: Horacio Garza Ghio, Health System General Director of CHRISTuS M u G ueRZA
Gustavo Fernandez, C eO at Grupo Torre Médica
Paula Garavito, Managing Director at AXA/Keralty
Cesar Carrasco, e xcecutive Managing Director at Hospitales San Angel Inn
11:30 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
12:30 GOING BEYOND THE VIDEO CALL: THE FUTURE OF STAKEHOLDER ENGAGEMENT
Speakers: Lance Hill, C eO of Within3
Estefanía Torres, Therapeutic Area Lead Immunology Director of Takeda
13:15 BETTER CARE THROUGH AN INTERCONNECTED HEALTH SYSTEM
Moderator: Georgina García, President of Cluster Médico Jalisco
Panelists: Jose Solis Padilla, Senior Administrator for International Business Development of Mayo Clinic
Jorge Camargo, C eO of eCAR e SO f T
Esteban López, MD Healthcare and Life Sciences Market Lead for the Americas at Google Cloud
Sandra Sánchez-Oldenhage, President of PharmAdvice
14:00 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
15:00 HEALTH SERVICES CONTINUITY: PANDEMIC AND POST-PANDEMIC SCENARIOS
Moderator: Américo García, VP and Director General of Apotex Latam
Panelists: Rafael Enrique Maciel Martínez, President of Asociación Mexicana de Genéricos (AMeGI)
Enrique Culebro Karam, Director of Central Media
Edilberto Peña de León, Director General of CIS ne Mexico
Iván Encalada Díaz, Vice President of Consejo Mexicano de Ortopedia y Traumatología AC
Leopoldo Cavazos Castro, Health Regulation Consultant at M yC Asociados
16:00 AN INTEGRAL APPROACH TO HEALTH PREVENTION
Moderator: Guillaume Corpart, Managing Director of Global Health Intelligence
Panelists: Jaime Fragoso, Director of Processing Centers of LMP
Eduardo Lara, Vice President, Head of Health Latin America at RGA
Fernando J. Cruz, Country President and Head of Corporate Affairs and Communication at n ovartis Group Mexico
Gabriela Allard, President at Mexican Diabetes Association
17:00 HEALTHCARE ACCESS AS A NATIONAL PRIORITY
Speaker: Manuel Cervantes Ocampo, Coordinator of first Level Medical u nits at IMSS
17:30 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
19:00 END OF DAY 1
09:00 COMPROMISED MEDICINE SUPPLY: THREAT TO PUBLIC HEALTH
Moderator: Rafael Gual, Director General of CAn I fARMA
Panelists: Orlando Aguirre, Government Sales Director, Market Access & Pricing of Merck Group
Benjamin Vega, Commercial Director of Allen Laboratories
Juan Luis Serrano Leets, Partner- Life Sciences at Sánchez Devanny
Jesús Arenas Wiedfeldt, Corporate Communication Director of Maypo
Enrique Liñero, Country Head at Sandoz
10:00 COUNTERFEIT DRUGS: THE IMPACT ON THE PHARMACEUTICAL INDUSTRY
Speaker: Gary Pond, Global Product Authentication Lead of Colorcon
10:45 ACCELERATED PATHWAYS FOR ACCESS TO PHARMACEUTICAL INNOVATION
Moderator: Cynthia Ramírez, Communications Director of AMII f
Panelists: Cristobal Thompson, e xecutive Director of AMII f
Florencia Davel, VP, General Manager, Latin America at Bristol Myers Squibb
Antonio Loaeza, Country Medical Director at Sanofi Genzyme
Angeles Martínez, Senior Principal and Head of Consulting, n orth LatAm at IQVIA
11:30 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
12:30 INTEGRATION OF HEALTH ECOSYSTEMS 5.0
Moderator: Alejandro Ruiz, Health Industry Global Head at Multiplica
Panelists: Carlos Flores, Chief Innovation Officer of n adro
Hector Sobrino, Director of Health Services and Transformation of AXA/Keralty
Jesus David Diaz Garaygordobil, CIO at CHRISTuS M u G ueRZA
13:15 IMPACT OF THE DIAGNOSIS IN THE FIGHT AGAINST ANTIMICROBIAL RESISTANCE
Moderator: David Godínez, Medical Advisor of bioMérieux
Panelists: Hector Barillas, Director General of bioMérieux
Suria González, Infectionist of bioMérieux
Julian Jiménez, Lab Specialist of bioMérieux
14:00 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
15:00 VALUE-BASED INVESTMENT FOR STATE-OF-THEART MEDICAL DEVICE TECHNOLOGY
Moderator: Ana Riquelme, e xecutive Director of AMID
Panelists: Alejandro Paolini, Managing Director - Mexico, Central America & the Caribbean at Siemens Healthineers
Juan Gabriel Gay, Managing Director at TI Salud
Héctor Orellana, VP n orth Latam at Medtronic
15:45 DATA: PRIVACY, OWNERSHIP, ETHICS, AND CYBERSECURITY
Moderator: Guillermo Bilbao, Director of energy Business Mexico of Minsait
Panelists: Fernando Gamallo, Director of Information Tchnology of Sanfer
José Arriaga Murcia, CIO at Tokio Marine Mexico
Pablo Cubela, IT Director of B u PA Mexico
Victor Medina, Acting President at HL7 Mexico
Grisell García Moncada, Head of Marketing at Acciona Mexico
16:30 WOMEN IN HEALTHCARE: THEIR EXPERIENCE AS INDUSTRY LEADERS
Moderator: Massiel Nunez, Director Americas at frontierView
Panelists: Florencia Davel, VP, General Manager, Latin America at Bristol Myers Squibb
María Johnson, VP of Channels for Latin America at Boston Scientific
Sandra Cifuentes, Latam Area Lead of Astellas
Luly de Samper, International Vice President, M eDICAL D e VIC e S, Latin America at Johnson & Johnson
Mariana Tolovi, Managing Director, Latin America at edwards Lifesciences
17:30 NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS
19:00 END OF MEXICO HEALTH SUMMIT 2021 ECHO